2023
Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes
Park D, Jamil Y, Hu J, Lowenstern A, Frampton J, Abdullah A, Damluji A, Ahmad Y, Soufer R, Nanna M. Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes. Cardiovascular Revascularization Medicine 2023, 57: 60-67. PMID: 37414611, PMCID: PMC10730763, DOI: 10.1016/j.carrev.2023.06.010.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionHospital mortalityHigher oddsOlder adultsHospital deliriumCoronary interventionAdverse health-related outcomesInpatient percutaneous coronary interventionNon-home dischargePeri-procedural settingAcute kidney injuryImpact of deliriumPost-procedural complicationsNational Inpatient SampleHealth-related outcomesDelirium preventionHospital complicationsMore comorbiditiesGastrointestinal hemorrhageKidney injuryAdverse eventsSecondary outcomesBlood transfusionPrimary outcomeIntracranial hemorrhageArrhythmias After Acute Myocardial Infarction
Frampton J, Ortengren A, Zeitler E. Arrhythmias After Acute Myocardial Infarction. The Yale Journal Of Biology And Medicine 2023, 96: 83-94. PMID: 37009192, PMCID: PMC10052595, DOI: 10.59249/lswk8578.Peer-Reviewed Original ResearchConceptsNon-ST-segment elevation myocardial infarctionST-segment elevation myocardial infarctionElevation myocardial infarctionMyocardial infarctionAcute myocardial infarctionHospital admissionAssociated with increased morbidityInfarctionIncidence of arrhythmiasBrady-arrhythmiasHospitalEpidemiologyReperfusion techniquesAdmissionIschemic arrhythmias
2022
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis
Park DY, Wang P, An S, Grimshaw AA, Frampton J, Ohman EM, Rao SV, Nanna MG. Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis. American Heart Journal 2022, 251: 101-114. PMID: 35654162, PMCID: PMC10904033, DOI: 10.1016/j.ahj.2022.05.019.Peer-Reviewed Original ResearchConceptsMonths of DAPTHazard ratioIschemic eventsDuration of DAPTSelect patient characteristicsDual antiplatelet therapyAcute coronary syndromeCoronary artery lesionsPercutaneous coronary interventionConfidence intervalsAssociation of outcomesRandom-effects modelComprehensive literature searchMeta-regression analysisMajor bleedingAntiplatelet therapyCoronary syndromeArtery lesionsCoronary interventionControlled TrialsPatient characteristicsPrespecified outcomesGreater proportionSimilar efficacySystematic review
2018
Modern Management of ST-Segment Elevation Myocardial Infarction
Frampton J, Devries J, Welch T, Gersh B. Modern Management of ST-Segment Elevation Myocardial Infarction. Current Problems In Cardiology 2018, 45: 100393. PMID: 30660333, DOI: 10.1016/j.cpcardiol.2018.08.005.Peer-Reviewed Original ResearchConceptsST-segment elevation myocardial infarctionDiagnosis of ST-segment elevation myocardial infarctionRestoration of coronary blood flowGuideline-directed therapyElevation myocardial infarctionCulprit coronary arteryManagement of ST-segment elevation myocardial infarctionSecondary prevention strategiesCoronary blood flowAntithrombotic therapyCoronary arteryMyocardial infarctionBlood flowPathophysiological foundationsThrombus formationPrevention strategiesTherapyIntracoronary plaqueComplicationsPathophysiologyPatients